Infectious Diseases in Critical Care Medicine

(ff) #1

  1. Graupner C, Vilacosta I, San Romain J, et al. Periannular extension of infective endocarditis. J Amer
    Coll Cardiol 2002; 39:1204–1212.

  2. Rohmann S, Erbel R, Gorge T, et al. Clinical relevance of vegetation localization by transesophageal
    echocardiography in infective endocarditis. Eur Heart J 1992; 12:446–452.

  3. Omari B, Shapiro S, Gintzon L, et al. Predictive risk factors for perivalvular extension of native
    valve endocarditis. Clinical and echocardiographic analyses. Chest 1989; 96:1273–1279.

  4. Goldenberger D, Kunzli A, Vogt P, et al. Molecular diagnosis of bacterial endocarditis by broad-
    range PCR amplification and direct sequencing. J Clin Microbiol 1997; 35:2733–2739.

  5. Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for diagnosis of infective
    endocarditis. Clin Infect Dis 2000; 30:633–644.

  6. Cunha BA. The mimics of endocarditis. In: Brusch JL, ed. Infective endocarditis, Management in the
    era of intravascular devices. New York: Informa Health Care, 2007:345–353.

  7. Rosenblum G, Carsons S. Mimics of endocarditis. In: Cunha B, ed. Infectious Diseases in Critical
    Care Medicine. New York: Marcel Dekker, 1998:435–434.

  8. Maksimowicz-McKinnon K, Mandell BF. Understanding valvular heart disease in patients with
    systemic autoimmune diseases. Cleve Clin J Med 2004; 11:881–885.

  9. Fisher J. Cardiac myxoma. Cardiovasc Rev Rep 1983; 9:1195–2001.

  10. Brusch JL. Surgical treatment of native valve and prosthetic valve infective endocarditis. In: Brusch
    JL, ed. Infective Endocarditis, Management in the Era of Intravascular Devices. New York: Informa
    Health Care, 2007:313–329.

  11. Bauernschmitt R, Jakob HG, Vahl C-F, et al. Operation for infective endocarditis: results after
    implementation of mechanical valves. Ann Thorac Surg 1998; 65:359–364.

  12. Wolff M, Witchitz S, Chastang C, et al. Prosthetic valve endocarditis in the ICU. Prognostic factors
    of overall survival in a series of 122 cases and consequences for treatment decision. Chest 1995;
    108:688–694.

  13. Truninger K, Attenhofer Jost CH, Seifert B, et al. Long-term follow-up of prosthetic valve
    endocarditis: what characteristics identify patients who were treated successfully with antibiotics
    alone? Heart 1999; 82:714–720.

  14. Bayer AS, Bolger AF, Taubert KA, et al. Diagnosis and management of infective endocarditis and its
    complications. Circulation 1998; 25:2936–2948.

  15. Olaison L, Hogevik H, Myken P, et al. Early surgery in infective endocarditis. QJM 1996; 89:267–278.

  16. Michel P, Vitoux B, Hage A. Early and delayed surgery in the acute native valve endocarditis. In:
    Horstkotte D, Bodnar E, eds. Infective Endocarditis. London: ICR Publishers, 1991:220–228.

  17. Magilligan D. Cardiac surgery in infective endocarditis. In: Horstkotte D, Bodnar E, eds. Infective
    Endocarditis. London: ICR publishers, 1991:210–218.

  18. Wilkoff BL, Byrd CL, Love CJ, et al. Pacemaker lead extraction with the laser sheath: results of the
    patient lead extraction with the excimer sheath (Plexes) trial. J Am Coll Cardiol 1999; 33:1671–1685.

  19. Lee BK, Crossley K, Gerding DN. The association between Staphylococcus aureus bacteremia and
    bacteruria. Am J Med 1978; 65:303–310.

  20. Torlakovic E, Hibbs JR, Miller JS, et al. Intracellular bacteria in blood smears in patients with central
    venous catheters. Arch Int Med 1995; 155:1547–1553.

  21. Fowler V, Li J, Core GR, et al. Role of echocardiography in evaluation of patients with
    Staphylococcus aureus bacteremia in 107 patients. J Am Coll 1997; 30:107–218.

  22. Dudale DC, Ramsey PG, Larson EB, et al. Hickman catheter infections in patients with
    malignancies. Medicine 1984; 63:189–200.

  23. Ascher DP, Shoupe BA, Maybee D, et al. Persistent catheter-related bacteremia: Clearance with
    antibiotics and urokinase. J Pediatr Surg 1993; 28:628–635.

  24. Ekkelenkamp MB, van der Bruggen T, van de Vijver D, et al. Bacteremic complications of
    intravascular catheters colonized with Staphylococcus aureus. Clin Infect Dis 2008; 46:114–118.

  25. Chang FY. A prospective multicenter study of Staphylococcus aureus bacteremia: Incidence of
    endocarditis, risk factors for mortality and clinical impact of methicillin-resistant. Medicine
    (Baltimore) 2003; 82:322–332.

  26. Joly V, Pangon B, Vallois JM, et al. Value of antibiotic levels in serum and cardiac vegetations for
    predicting antibacterial effect of ceftriaxone in experimental E. coli endocarditis. Antimicrob Agents
    Chemoter 1987; 31:1632–1635.

  27. Gengo F, Schentag J. Rate of methicillin penetration into normal heart valves and experimental
    endocarditis lesions. Antimicrob Agents Chemother 1982; 21:456–459.

  28. Fraimow HJ, Abrutyn E. Pathogens resistant to antimicrobial agents: Epidemiology, molecular
    mechanisms and clinical and management. Infect Dis Clin North Am 1995; 497–530.

  29. Douglas A, Moore-Gillon J, Eykyn J. Fever during treatment of infective endocarditis. Lancet 1986;
    1:1341–1343.


256 Brusch

Free download pdf